Editor
Georgiana Mihalache
- Fields
- Companies, Health, Analysis
- Writing for ZF since
- 2021
- Articles
- 226
Trident Aims to Open First Dental Clinic Outside Bucharest, in Timisoara
Florin Lazarescu, founder of Trident stomatology clinics, with three units in Bucharest, wants to open the first clinic outside the capital city, in Timisoara.
Fiterman Pharma Sees Turnover and Profit Drop in 2023
Fiterman Pharma, the drug producer controlled by Fiterman family of Iasi, in 2023 saw its turnover go down by almost 10%, while profit halved.
Pharmacy Network Myosotis Hits RON385M Turnover in 2023, Up 22% YOY
Myosotis brand, which has 146 pharmacies across several counties, reached RON385 million turnover in 2023, a figure comprising three companies the pharma retailer operates.
Six Biggest Drug Makers in Romania Set to Invest RON350M in Plants in Coming Year
The investment level planned by the six largest drug makers in the plants they have in Romania reaches RON350 million in the 2024-2025 period, in line with ZF calculations, as projects are s...
Medima Health Aims to Reach 22 Clinics at End-2024
Medima Health, a player on the medical imaging market set up four years ago, wants to reach 22 clinics by end-2024, after having already opened two units in Deva and Resita.
Fildas-Catena Group Reaches RON14B Cumulated Turnover in 2023, Up 14% YOY
Fildas-Catena group, the largest player on the pharma market, founded by entrepreneur Anca Vlad three decades ago, registered RON14 billion cumulated turnover in 2023.
Nova Vita Hospital 2023 Turnover Tops RON40M, Up 11% YOY
Nova Vita hospital of Targu-Mures, a 170-bed unit founded 14 years ago, ended 2023 with turnover worth almost RON42 million, up 11% from 2022.
Lego Romania Turnover Up 16% in 2023
Denmark’s Lego reached RON236 million turnover in Romania in 2023, up 16% from the previous year.
Antibiotice Iasi Eyes RON850M Investments by 2030
Antibiotice Iasi, the largest Romanian-held drug maker, has a total RON850 million investment plan between 2023-2030 to reach RON1 billion turnover at the end of this period.
Terapia Has EUR25M Investments Earmarked for Cluj Plant
Dragos Damian, CEO of Terapia Cluj, announced in an interview with ZF the company has over EUR10 million worth of investments underway in new manufacturing technologies, expansion of end pro...
Drugmaker Zentiva Wants to Join “Billionaires’ League” in 2024
Drugmaker Zentiva has budgeted net revenues of above RON1.1 billion in 2024, up 20% from 2023 level, which would mark the company’s joining the RON billionaires’ league.
Antibiotice Iasi Wants to Cross RON100M Profit Threshold in 2024
Antibiotice Iasi, the biggest Romanian-held drug manufacturer, wants to reach RON104 million net profit in 2024, up 28% from 2023, in line with its income and expenses budget.